Nifty
Sensex
:
:
11456.90
38164.61
-64.15 (-0.56%)
-222.14 (-0.58%)

Pharmaceuticals & Drugs

Rating :
47/99

BSE: 524280 | NSE: KOPRAN

40.55
-0.15 (-0.37%)
22-Mar-2019 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  40.60
  •  41.40
  •  40.40
  •  40.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  23544
  •  9.55
  •  74.65
  •  32.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 175.61
  • 8.18
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 258.26
  • N/A
  • 1.09

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 43.78%
  • 6.71%
  • 43.59%
  • FII
  • DII
  • Others
  • 2.69%
  • 0.00%
  • 3.23%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.20
  • 0.68
  • 1.88

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 29.56
  • -7.37
  • -0.79

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 3.59
  • 24.10

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.86
  • 11.54
  • 12.98

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.71
  • 2.19
  • 2.09

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.19
  • 7.92
  • 8.14

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
105.49
94.33
11.83%
92.15
72.82
26.54%
60.55
51.29
18.05%
96.27
96.59
-0.33%
Expenses
89.61
85.08
5.32%
82.08
65.90
24.55%
56.84
47.77
18.99%
85.56
82.07
4.25%
EBITDA
15.88
9.25
71.68%
10.07
6.92
45.52%
3.71
3.52
5.40%
10.71
14.51
-26.19%
EBIDTM
15.05%
9.81%
10.93%
9.50%
6.13%
6.86%
11.12%
15.03%
Other Income
1.78
4.16
-57.21%
0.28
1.89
-85.19%
1.48
2.21
-33.03%
1.34
2.98
-55.03%
Interest
2.15
1.46
47.26%
2.79
2.15
29.77%
1.61
2.59
-37.84%
2.40
4.44
-45.95%
Depreciation
2.18
2.15
1.40%
2.19
2.14
2.34%
2.15
2.10
2.38%
2.12
2.21
-4.07%
PBT
13.33
9.80
36.02%
5.38
4.52
19.03%
1.43
1.04
37.50%
7.53
10.85
-30.60%
Tax
2.47
0.00
0.00
1.08
0.00
0.00
0.25
0.00
0.00
2.40
4.85
-50.52%
PAT
10.86
9.80
10.82%
4.30
4.52
-4.87%
1.18
1.04
13.46%
5.13
6.00
-14.50%
PATM
10.30%
10.39%
4.66%
6.21%
1.95%
2.03%
5.32%
6.21%
EPS
2.51
2.27
10.57%
0.99
1.05
-5.71%
0.27
0.24
12.50%
1.19
1.39
-14.39%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
354.46
313.32
309.72
296.32
325.73
302.85
250.22
198.90
192.38
164.36
118.63
Net Sales Growth
12.52%
1.16%
4.52%
-9.03%
7.55%
21.03%
25.80%
3.39%
17.05%
38.55%
 
Cost Of Goods Sold
207.52
171.87
164.89
166.92
194.27
172.22
141.88
116.77
114.40
96.14
72.32
Gross Profit
146.94
141.44
144.82
129.39
131.46
130.63
108.34
82.13
77.99
68.22
46.31
GP Margin
41.45%
45.14%
46.76%
43.67%
40.36%
43.13%
43.30%
41.29%
40.54%
41.51%
39.04%
Total Expenditure
314.09
284.27
273.60
266.09
294.29
260.25
216.57
177.75
174.33
147.83
116.45
Power & Fuel Cost
-
14.67
13.71
14.10
12.93
11.71
11.13
8.56
9.03
8.70
7.78
% Of Sales
-
4.68%
4.43%
4.76%
3.97%
3.87%
4.45%
4.30%
4.69%
5.29%
6.56%
Employee Cost
-
32.24
31.37
28.02
28.83
23.01
21.03
17.98
17.85
16.30
14.35
% Of Sales
-
10.29%
10.13%
9.46%
8.85%
7.60%
8.40%
9.04%
9.28%
9.92%
12.10%
Manufacturing Exp.
-
32.55
31.84
27.80
25.56
22.44
17.79
15.85
16.17
10.61
10.45
% Of Sales
-
10.39%
10.28%
9.38%
7.85%
7.41%
7.11%
7.97%
8.41%
6.46%
8.81%
General & Admin Exp.
-
16.79
16.93
15.68
15.38
14.46
11.32
9.86
9.08
9.70
6.22
% Of Sales
-
5.36%
5.47%
5.29%
4.72%
4.77%
4.52%
4.96%
4.72%
5.90%
5.24%
Selling & Distn. Exp.
-
9.56
8.46
9.35
8.16
8.85
6.56
5.85
4.64
4.45
2.47
% Of Sales
-
3.05%
2.73%
3.16%
2.51%
2.92%
2.62%
2.94%
2.41%
2.71%
2.08%
Miscellaneous Exp.
-
6.59
6.39
4.22
9.17
7.57
6.87
2.88
3.18
1.93
2.47
% Of Sales
-
2.10%
2.06%
1.42%
2.82%
2.50%
2.75%
1.45%
1.65%
1.17%
2.41%
EBITDA
40.37
29.05
36.12
30.23
31.44
42.60
33.65
21.15
18.05
16.53
2.18
EBITDA Margin
11.39%
9.27%
11.66%
10.20%
9.65%
14.07%
13.45%
10.63%
9.38%
10.06%
1.84%
Other Income
4.88
10.94
10.66
2.37
6.54
1.96
1.81
5.66
6.45
1.96
3.94
Interest
8.95
8.60
13.70
12.56
12.97
14.46
11.88
9.66
8.61
6.18
8.56
Depreciation
8.64
8.51
8.33
8.12
9.64
12.92
12.46
11.80
11.62
11.55
11.37
PBT
27.67
22.89
24.76
11.91
15.36
17.18
11.12
5.34
4.26
0.77
-13.81
Tax
6.20
2.40
4.85
0.00
0.00
0.00
0.00
0.00
-0.27
0.62
-0.02
Tax Rate
22.41%
10.48%
19.59%
0.00%
0.00%
0.00%
0.00%
0.00%
-6.34%
8.24%
0.14%
PAT
21.47
20.49
19.91
10.72
-39.12
17.18
11.12
5.34
4.53
6.90
-13.79
PAT before Minority Interest
21.47
20.49
19.91
10.72
-39.12
17.18
11.12
5.34
4.53
6.90
-13.79
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.06%
6.54%
6.43%
3.62%
-12.01%
5.67%
4.44%
2.68%
2.35%
4.20%
-11.62%
PAT Growth
0.51%
2.91%
85.73%
-
-
54.50%
108.24%
17.88%
-34.35%
-
 
Unadjusted EPS
4.96
4.74
4.60
2.59
-9.84
4.40
2.85
1.37
1.10
-0.05
-4.00

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
144.71
124.67
108.72
98.52
114.56
97.22
86.02
80.46
74.50
65.42
Share Capital
43.25
43.25
51.83
49.68
47.63
47.63
47.63
47.63
45.68
43.83
Total Reserves
101.46
81.42
56.89
34.65
66.93
49.59
38.39
32.84
28.33
20.52
Non-Current Liabilities
31.45
32.17
33.00
18.31
67.02
73.34
68.00
76.19
109.90
114.19
Secured Loans
0.44
0.33
0.33
0.63
0.68
2.94
5.49
7.42
33.75
41.27
Unsecured Loans
29.48
32.17
28.36
13.38
62.54
66.54
59.10
65.83
76.15
73.57
Long Term Provisions
5.14
4.59
4.31
4.31
3.55
3.60
3.16
2.84
0.00
0.00
Current Liabilities
135.53
136.49
122.08
158.21
117.45
92.75
96.43
80.65
50.03
55.62
Trade Payables
61.67
47.13
57.04
69.22
35.71
46.98
41.82
30.74
41.56
36.00
Other Current Liabilities
20.30
29.91
26.64
36.70
29.33
20.74
22.85
18.72
5.77
17.43
Short Term Borrowings
52.11
56.09
38.00
51.38
52.27
24.90
31.66
31.01
0.00
0.00
Short Term Provisions
1.45
3.36
0.41
0.90
0.14
0.12
0.12
0.18
2.71
2.20
Total Liabilities
311.69
293.33
263.80
275.04
299.03
263.31
250.45
237.30
234.43
235.23
Net Block
104.44
104.47
100.88
101.56
104.89
108.51
114.32
115.21
121.60
130.69
Gross Block
121.27
112.80
314.06
306.73
295.95
286.76
280.31
269.40
264.30
262.01
Accumulated Depreciation
16.84
8.33
213.18
205.18
191.06
178.25
165.99
154.19
142.69
131.32
Non Current Assets
117.96
113.62
109.78
105.06
139.33
140.69
143.91
147.76
145.31
165.05
Capital Work in Progress
9.93
6.29
3.13
1.23
19.76
19.85
18.92
18.96
19.18
33.15
Non Current Investment
0.05
0.05
0.11
0.11
0.81
0.81
0.81
0.96
4.52
1.22
Long Term Loans & Adv.
2.23
2.30
5.61
2.09
13.76
11.43
9.83
9.93
0.00
0.00
Other Non Current Assets
1.31
0.50
0.03
0.06
0.10
0.09
0.02
2.70
0.00
0.00
Current Assets
193.74
179.72
154.01
169.98
159.70
122.61
106.54
89.55
89.11
70.18
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
71.01
60.56
58.84
45.30
53.02
36.74
35.15
32.11
26.16
15.58
Sundry Debtors
64.77
73.11
56.89
81.17
56.03
51.18
39.01
34.49
29.17
22.46
Cash & Bank
6.18
6.88
4.71
3.73
4.71
3.79
9.66
0.86
4.79
2.17
Other Current Assets
51.78
1.83
0.93
1.55
45.93
30.91
22.73
22.09
28.99
29.97
Short Term Loans & Adv.
47.57
37.33
32.65
38.23
45.02
29.53
21.46
21.46
23.36
29.97
Net Current Assets
58.20
43.23
31.93
11.78
42.25
29.86
10.11
8.90
39.09
14.56
Total Assets
311.70
293.34
263.79
275.04
299.03
263.30
250.45
237.31
234.42
235.23

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
25.88
15.87
28.63
46.30
2.79
14.88
35.01
17.79
3.47
8.25
PBT
22.89
24.76
10.72
-39.12
17.18
11.12
5.34
4.26
0.77
-13.81
Adjustment
13.52
25.15
19.63
76.87
25.97
22.52
18.74
21.51
16.15
18.06
Changes in Working Capital
-7.45
-33.13
-1.71
8.58
-40.32
-18.68
10.88
-7.89
-20.19
3.97
Cash after chg. in Working capital
28.95
16.78
28.64
46.32
2.82
14.95
34.96
17.88
-3.27
8.22
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-3.07
-0.91
-0.01
-0.02
-0.04
-0.07
0.04
-0.09
-0.02
0.02
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-11.07
-17.96
-9.07
-9.62
-9.33
-9.31
-9.81
1.01
8.26
9.80
Net Fixed Assets
-5.43
35.65
-4.54
195.52
-8.75
-7.37
-10.87
-4.91
-2.54
-7.33
Net Investments
-0.32
-0.53
-110.00
-39.20
0.00
0.00
0.00
3.52
-3.33
15.54
Others
-5.32
-53.08
105.47
-165.94
-0.58
-1.94
1.06
2.40
14.13
1.59
Cash from Financing Activity
-15.02
1.97
-19.34
-36.90
6.69
-12.14
-18.84
-18.70
-9.11
-18.23
Net Cash Inflow / Outflow
-0.21
-0.12
0.22
-0.22
0.14
-6.56
6.35
0.10
2.62
-0.19
Opening Cash & Equivalents
0.66
0.78
0.56
0.79
0.65
7.21
0.86
0.76
2.17
2.35
Closing Cash & Equivalent
0.44
0.66
0.78
0.56
0.79
0.65
7.21
0.86
4.79
2.17

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
33.46
28.83
23.15
18.43
27.14
22.70
19.83
18.41
17.64
15.82
ROA
6.77%
7.15%
3.98%
-13.63%
6.11%
4.33%
2.19%
1.92%
2.94%
-5.46%
ROE
15.21%
17.71%
12.19%
-43.06%
17.65%
13.39%
7.15%
6.60%
11.39%
-23.69%
ROCE
13.88%
19.24%
13.09%
-12.48%
14.27%
11.81%
7.92%
6.88%
7.51%
-2.69%
Fixed Asset Turnover
2.69
1.49
0.98
1.11
1.07
0.91
0.75
0.75
0.64
0.46
Receivable days
79.96
74.44
82.54
74.79
62.68
63.96
65.44
58.23
55.80
74.37
Inventory Days
76.30
68.37
62.26
53.60
52.48
50.98
59.89
53.30
45.11
59.37
Payable days
72.95
73.61
89.54
68.97
60.02
75.95
75.92
76.75
94.58
104.18
Cash Conversion Cycle
83.30
69.21
55.25
59.43
55.14
38.99
49.41
34.78
6.32
29.56
Total Debt/Equity
0.61
0.76
0.65
0.92
1.12
1.06
1.20
1.36
1.48
1.78
Interest Cover
3.66
2.81
1.85
-2.02
2.19
1.94
1.55
1.50
2.22
-0.61

News Update:


  • USFDA completes inspection at Kopran's arm facility
    25th Jan 2019, 15:35 PM

    The Inspection has been completed without issuance of any observation

    Read More
  • Kopran - Quarterly Results
    21st Jan 2019, 17:43 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.